查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016931

泌尿系統醫療設備市場：按產品類型、技術、應用和最終用戶分類 - 全球市場預測（2026-2032 年）

Urology Devices Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，泌尿系統醫療設備市場價值將達到 325.2 億美元，到 2026 年將成長至 348.2 億美元，到 2032 年將達到 564.7 億美元，複合年成長率為 8.20%。

主要市場統計數據
基準年（2025 年） 325.2億美元
預計年份（2026年） 348.2億美元
預測年份（2032年） 564.7億美元
複合年成長率 (%) 8.20%

概述受人口結構、臨床創新、監管變化和以價值為基礎的醫療保健趨勢驅動的泌尿系統醫療設備市場的發展現狀。

現代泌尿系統醫療設備市場呈現多種因素交會的特點，迫切需要明確的策略方向。人口老化、臨床指南不斷更新以推廣微創手術，以及患者對更快康復和更高生活品質的日益成長的期望，都在重塑醫療設備設計的優先順序。同時，臨床醫師和醫療服務提供者也要求醫療設備能夠提供更強的臨床證據、簡化工作流程，並能無縫整合到現有的臨床流程中。

變革性的技術和臨床變化正在重塑泌尿系統護理路徑，從微創系統轉向數位診斷和綜合手術平台。

近年來，泌尿系統診療模式和醫療設備設計概念發生了翻天覆地的變化。小型化和影像技術的進步使得診斷和治療更加微創，降低了病患併發症的風險，並促進了門診手術的進行。同時，能量傳遞系統、雷射技術和精準的結石治療工具不斷拓展治療選擇，使臨床醫生能夠為每位患者量身定做更具特異性的治療方案。

評估 2025 年生效的美國新關稅對泌尿系統醫療設備的供應鏈、籌資策略、成本和臨床採購慣例的累積影響。

美國2025年實施的關稅對全球供應鏈產生了連鎖反應，直接影響了泌尿系統醫療設備的採購決策、成本結構和採購慣例。嚴重依賴跨境零件採購的製造商面臨原料成本飆升和利潤率承壓的困境，迫使許多製造商實現供應商多元化、將生產轉移到近岸地區，並重新評估庫存策略。因此，醫院、門診和專科診所的採購團隊在評估供應商合約時面臨更艱難的談判，整體擁有成本（TCO）的重要性也再次凸顯。

利用產品類型、技術、臨床應用和最終用戶等方面的詳細細分洞察，制定有針對性的投資和商業化策略。

詳細的細分分析明確了投資和臨床開發的重點方向。依產品類型分類，泌尿系統管理領域涵蓋介入性器械、非介入性器械和陰莖人工替代物，每種器械都針對不同的臨床需求和報銷途徑。內視鏡器械包括膀胱鏡、腎鏡和輸尿管鏡，每種器械提供的視野和治療環境各不相同。結石治療器械包括雷射系統、體外震波碎石機和取石器械，每種器械的資本投入和操作人員訓練要求各不相同。輸尿管支架分為藥物釋放型支架、金屬支架和聚合物支架，每種支架在通暢性和生物相容性方面都有不同的特性。尿道導管種類繁多，從外置導尿管和Foley導管到間歇導尿管，每種導管都有其獨特的感染控制和患者便利性方面的考慮。此外，肌電圖系統和壓力-流量分析儀等尿動力學設備有助於提高診斷準確性並最佳化治療路徑。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和採用模式正在重新定義製造業、監管和市場進入。

區域趨勢對創新採納、監管預期和商業策略有顯著影響。在美洲，醫療保健系統融合了集中採購和分散的醫療服務提供者決策模式，重點關注明確的臨床經濟證據、與醫院系統的互通性以及完善的上市後支援。北美醫療服務提供者通常優先考慮手術效率與治療結果之間的關聯，因此對能夠縮短住院時間和擴大門診服務範圍的技術越來越感興趣。

泌尿系統醫療設備領導企業的策略行動和競爭定位：強調創新、夥伴關係、生產製造和臨床證據策略

泌尿系統醫療設備領域的主要企業正採用多元化策略來維持成長和臨床影響力。許多公司優先考慮產品組合多元化，在利潤率高的資本設備與耗材的持續收入之間取得平衡，從而確保即使在需求波動時期也能保持穩定。投資趨勢不僅關注核心醫療設備的效能，還關注影像導引導航、數據分析和軟體驅動的工作流程等相關功能，這些功能有助於提高臨床醫生的工作效率和治療效果。

為行業領導者提供切實有效的建議，以應對供應中斷和監管複雜性，並加速採用新的泌尿系統技術。

產業領導者應採取一系列切實可行的步驟，將洞察轉化為可衡量的成果。首先，他們應實現供應鏈多元化，並尋求區域製造夥伴關係，以增強應對貿易中斷的能力並縮短前置作業時間。同時，也應保持合約的柔軟性，以便根據不斷變化的關稅和物流環境調整價格和交貨條件。其次，他們應優先投資在門診環境中展現出明確臨床和經濟價值的技術。例如，能夠簡化內視鏡檢查流程的平台，以及能夠減輕消毒負擔和降低感染風險的一次性醫療器材。

本文檔概述了一種高度透明的調查方法，用於在泌尿系統產生可靠的知識，包括初步訪談、二手資訊、專家檢驗和三角測量技術。

支持這些發現的研究途徑是基於一種強調嚴謹性、透明度和三角驗證的多方面調查方法。主要研究包括對臨床醫生、採購經理、監管專家和行業高管進行結構化訪談，以了解他們對臨床需求、採購行為和推廣障礙的第一手觀點。這些定性資訊輔以對同儕審查的臨床文獻、監管指導文件和最佳治療實踐的系統性回顧，以確保與目前的護理標準保持一致。

摘要重點介紹了泌尿系統醫療設備生態系統中各相關人員的策略機會、風險緩解策略和關鍵轉折點。

總之，泌尿系統醫療設備的現況受多種因素共同影響：臨床上對微創高效治療方法的需求、推動精準醫療和數據整合的技術進步，以及供應鏈趨勢和不斷變化的報銷模式帶來的商業性壓力。這些趨勢既帶來了挑戰，也帶來了機會。在日益以價值為導向的市場環境中，那些投資於具有臨床意義的創新、建立穩健的供應鏈以及開展循證商業化的機構，將能夠在競爭中脫穎而出。

目錄

第1章 引言

第2章 分析方法

  • 分析設計
  • 分析框架
  • 市場規模預測
  • 數據三角測量
  • 分析結果
  • 分析的前提條件
  • 分析的局限性

第3章執行摘要

  • 首席體驗長的觀點
  • 市場規模和成長趨勢
  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入（GTM）策略

第5章 市場洞察

  • 消費者分析與最終用戶觀點
  • 消費者體驗基準測試
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 成本效益分析（ROI）和成本效益分析（CBA）

第6章：美國關稅的累積影響（2025 年）

第7章：人工智慧（AI）的累積影響（2025 年）

第8章：泌尿系統醫療設備市場：依產品類型分類

  • 尿失禁管理
    • 介入裝置
    • 非介入性設備
    • 陰莖人工替代物
  • 內視鏡設備
    • 膀胱鏡
    • 腎鏡
    • 輸尿管鏡
  • 石材管理設備
    • 雷射系統
    • 體外震波碎石裝置
    • 石材移除設備
  • 輸尿管支架
    • 藥物釋放型支架
    • 金屬支架
    • 聚合物支架
  • 尿道導管
    • 外導管
    • Foley導管
    • 間歇性導尿管
  • 尿動力學設備
    • 圖（EMG）系統
    • 尿流壓力測量裝置

第9章：泌尿系統醫療設備市場：依技術分類

  • 一次性
  • 可重複使用類型

第10章：泌尿系統醫療設備市場：依應用領域分類

  • 良性攝護腺增生
  • 膀胱癌
  • 腎結石
  • 尿失禁
  • 尿道感染

第11章：泌尿系統醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 泌尿系統診所

第12章：泌尿系統醫療設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：泌尿系統醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：泌尿系統醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國泌尿系統醫療設備市場

第16章：中國泌尿系統醫療設備市場

第17章 競爭格局

  • 市場集中度分析（2025 年）
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析（2025 年）
  • 產品系列分析（2025 年）
  • 基準分析（2025 年）
  • Boston Scientific Corporation
  • Coloplast A/S
  • Cook Medical LLC
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Stryker Corporation
  • Teleflex Incorporated
Product Code: MRR-034B50030338

The Urology Devices Market was valued at USD 32.52 billion in 2025 and is projected to grow to USD 34.82 billion in 2026, with a CAGR of 8.20%, reaching USD 56.47 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 32.52 billion
Estimated Year [2026] USD 34.82 billion
Forecast Year [2032] USD 56.47 billion
CAGR (%) 8.20%

A concise introduction to the evolving urology devices landscape driven by demographics, clinical innovation, regulatory changes and value-based care dynamics

The contemporary landscape for urology devices is characterized by intersecting drivers that amplify the urgency for strategic clarity. Demographic shifts toward older populations, evolving clinical guidelines that favor minimally invasive procedures, and growing patient expectations for faster recovery and improved quality of life are collectively reshaping device design priorities. Concurrently, clinicians and healthcare providers are demanding stronger clinical evidence, streamlined workflows, and devices that integrate seamlessly into existing care pathways.

Regulatory agencies have intensified scrutiny on safety and post-market surveillance, while reimbursement frameworks increasingly prioritize value and outcomes over procedural volume. These forces, together with rapid technology maturation in imaging, energy-based lithotripsy, and biomaterials, are accelerating product iteration cycles. As a result, stakeholders from manufacturers to providers must balance speed to market with robust clinical validation to maintain trust and ensure adoption.

Ultimately, success in this environment depends on aligning R&D investments with pragmatic commercial strategies, cultivating payer and provider relationships, and designing devices that deliver measurable clinical and economic benefits. By focusing on interoperability, clinician ergonomics, and patient-centered outcomes, organizations can position their portfolios to address immediate clinical needs while remaining adaptable to emerging care models.

Transformative technological and clinical shifts reshaping urology care pathways from minimally invasive systems to digital diagnostics and integrated surgical platforms

Recent years have witnessed transformative shifts that are redefining how urology care is delivered and how devices are conceived. Advances in miniaturization and imaging are enabling less invasive diagnostics and therapies, reducing patient morbidity and facilitating procedures in ambulatory settings. At the same time, energy delivery systems, laser technologies, and precision-driven stone management tools are expanding therapeutic options and enabling clinicians to tailor interventions with greater specificity.

Digital health and data-driven approaches are also gaining traction, as integrated software, procedural analytics, and remote monitoring enhance postoperative care and support longitudinal outcome measurement. Furthermore, there is a clear movement toward single-use disposables in procedural environments where infection control, sterilization logistics, and workflow efficiency are paramount. This trend coexists with renewed interest in reusables where lifecycle cost and environmental considerations can be responsibly managed through improved sterilization technologies.

In parallel, regulatory pathways are evolving to better accommodate combination products and device-drug integrations, such as drug-eluting stents and antimicrobial-coated catheters. As a result, commercialization strategies increasingly rely on cross-functional capabilities that span clinical research, regulatory affairs, supply chain resilience, and payer engagement. Stakeholders that proactively adapt to these shifts will be better placed to convert technological promise into durable clinical adoption.

Assessing the cumulative effects of new United States tariffs in 2025 on urology device supply chains, sourcing strategies, costs and clinical procurement practices

The imposition of United States tariffs in 2025 created a ripple effect across global supply chains that directly affected sourcing decisions, cost structures, and procurement practices for urology devices. Manufacturers that relied heavily on cross-border component sourcing confronted elevated input costs and compressed margins, prompting many to reassess supplier diversification, nearshoring, and inventory strategies. As a consequence, procurement teams in hospitals, ambulatories, and specialty clinics faced tighter negotiations and a renewed emphasis on total cost of ownership when evaluating vendor contracts.

Moreover, the tariffs fostered a recalibration of product portfolios. High-volume consumables and devices with thin margins saw intensified pressure to localize manufacturing or to redesign for cost-effective production without compromising clinical performance. In response, several manufacturers prioritized modular platforms and standardized components to mitigate tariff-related price volatility, while others accelerated partnerships with regional contract manufacturers to preserve supply continuity. These shifts also influenced the strategic balance between disposable and reusable device offerings, with decision makers weighing the trade-offs between upfront capital costs, sterilization logistics, and ongoing consumable spend.

Clinicians and procurement leaders consequently adapted adoption timelines and device selection criteria, placing greater weight on demonstrable efficiencies and training resources that reduce procedural time and resource utilization. Looking forward, organizational resilience will depend on transparent supplier ecosystems, contractual flexibility, and the ability to translate cost pressures into differentiated value propositions for providers and patients.

Deep segmentation insights across product types, technologies, clinical applications and end users to inform targeted investment and commercialization strategies

A nuanced view of segmentation clarifies where investment and clinical development should be concentrated. Within product typology, continence management spans interventional devices, noninterventional devices, and penile prostheses, each responding to distinct clinical needs and reimbursement pathways; endoscopy devices include cystoscopes, nephroscopes, and ureteroscopes that differ by visualization capabilities and procedural settings; stone management devices encompass laser systems, lithotripsy devices, and stone removal tools that vary in capital intensity and operator training requirements; ureteral stents are differentiated across drug-eluting stents, metal stents, and polymer stents with divergent profiles for patency and biocompatibility; urinary catheters range from external catheters and Foley catheters to intermittent catheters each with unique infection control and patient usability considerations; and urodynamic devices such as EMG systems and pressure flow analyzers support diagnostic precision and care pathway optimization.

Separately, technology segmentation between disposable and reusable devices has strategic implications for manufacturing, sterilization logistics, and environmental considerations. Disposable solutions can accelerate adoption in infection-sensitive environments and reduce sterilization overhead, while reusable systems justify higher capital investment through lower per-procedure consumable costs over time when supported by robust sterilization protocols.

Application-based segmentation highlights clinical focus areas including benign prostatic hyperplasia, bladder cancer, kidney stones, urinary incontinence, and urinary tract infections, each presenting unique procedural mixes, follow-up regimens, and device design constraints. End-user segmentation across ambulatory surgical centers, hospitals, and urology clinics underscores variation in purchase cycles, capital availability, procedural throughput, and training resources. Together, these segmentation lenses guide prioritization of product development, clinical evidence generation, and go-to-market initiatives that align with real-world practice settings.

Regional dynamics and adoption patterns across the Americas, Europe Middle East & Africa and Asia-Pacific that are redefining manufacturing, regulation and market access

Regional dynamics exert a powerful influence on innovation adoption, regulatory expectations, and commercial strategy. In the Americas, healthcare systems display a mix of centralized procurement and fragmented provider decision making, which places a premium on clear clinical-economic evidence, interoperability with hospital systems, and robust post-market support. North American providers often prioritize procedural efficiency and outcomes linkage, driving interest in technologies that reduce length of stay and support ambulatory care expansion.

In Europe, Middle East & Africa, diverse regulatory landscapes and reimbursement models create both complexity and opportunity. Several countries in this region favor strong clinical evidence and cost-effectiveness demonstrations, while others offer pathways for rapid adoption through specialist centers of excellence. Local manufacturing capabilities and regional trade frameworks also influence sourcing decisions, making partnerships with regional distributors and contract manufacturers an essential part of market entry strategies.

Asia-Pacific presents heterogeneous adoption patterns driven by rapidly modernizing healthcare infrastructure in some markets and constrained capital in others. High procedure volumes and growing demand for minimally invasive options make the region attractive for scalable device platforms and cost-optimized consumables. Across all regions, attention to training, local clinical champions, and supply chain reliability remains essential to achieving durable adoption and patient access.

Strategic corporate behaviors and competitive positioning of leading urology device companies highlighting innovation, partnerships, manufacturing and clinical evidence strategies

Leading companies in the urology device space are adopting multifaceted strategies to sustain growth and clinical relevance. Many prioritize portfolio diversification that balances high-margin capital equipment with consumable recurring revenue, enabling stability through cyclical demand. Investment patterns emphasize not only core device performance but also adjacent capabilities such as image-guided navigation, data analytics, and software-enabled workflows that enhance clinician productivity and procedural outcomes.

Strategic partnerships, licensing agreements, and targeted acquisitions are common approaches to accelerate access to specialized technologies, broaden clinical reach, and enter new geographic markets. At the same time, establishing robust clinical evidence programs and sponsoring investigator-initiated studies remain central to building credibility with urology thought leaders and payers. Manufacturing resilience features prominently in corporate planning, with investments in dual sourcing, quality systems, and regional production to reduce tariff exposure and inventory risk.

Commercially, companies are optimizing their engagement models with end users by creating dedicated training programs, procedural support, and bundled service offerings. These moves help lower adoption barriers and create deeper clinical integration. Organizations that combine operational excellence with focused R&D and clinician-centric commercial strategies are best positioned to sustain long-term competitiveness in a rapidly evolving landscape.

Practical, high-impact recommendations for industry leaders to navigate supply disruptions, regulatory complexity and accelerate adoption of novel urology technologies

Industry leaders should adopt a set of pragmatic actions to translate insight into measurable outcomes. First, diversify supply sources and pursue regional manufacturing partnerships to enhance resilience against trade disruptions and to shorten lead times. This should be accompanied by contractual flexibility that allows pricing and delivery terms to reflect evolving tariff and logistics environments. Second, prioritize investments in technologies that demonstrate clear clinical and economic value in ambulatory settings, such as streamlined endoscopy platforms and single-use devices that reduce sterilization burden and infection risk.

Third, strengthen clinical evidence generation by designing comparative studies that measure patient-centered outcomes and total cost of care, thereby improving payer engagement and facilitating value-based contracting. Fourth, leverage digital health integration to offer providers procedural analytics and remote monitoring capabilities that enhance postoperative management and support long-term patient outcomes. Fifth, refine commercialization approaches by tailoring messaging and pricing to specific end users: ambulatory surgical centers will respond to throughput improvements, hospitals to integrated systems and lifecycle costs, and specialized clinics to device ergonomics and ease of use.

Finally, invest in workforce enablement through comprehensive training, simulation, and procedural support programs to reduce adoption friction. By combining supply chain prudence, evidence-focused R&D, and clinically aligned commercialization, organizations can accelerate adoption while minimizing operational risk.

Transparent research methodology outlining primary interviews, secondary sources, expert validation and triangulation techniques used to produce robust urology insights

The research approach underpinning these insights is anchored in a blended methodology that emphasizes rigor, transparency, and triangulation. Primary research included structured interviews with clinicians, procurement leaders, regulatory specialists, and industry executives to capture frontline perspectives on clinical needs, purchasing behavior, and adoption barriers. These qualitative inputs were complemented by a systematic review of peer-reviewed clinical literature, regulatory guidance documents, and procedural best practices to ensure alignment with contemporary standards of care.

To validate and refine findings, expert panels were convened to challenge assumptions and provide domain-specific nuance. Quantitative data points were cross-checked through multiple independent sources where available, and sensitivity analyses were applied to identify robust trends versus transient market noise. Segmentation frameworks were derived from clinical workflows, device functionality, and end-user characteristics to produce actionable insights that align with real-world decision making.

Quality control measures included iterative peer review, source traceability, and methodological transparency so stakeholders can assess the confidence and applicability of conclusions. Where uncertainty exists, the research explicitly highlights contingent factors and scenario considerations to support strategic planning and risk mitigation.

Concluding synthesis that highlights strategic opportunities, risk mitigations and the critical inflection points for stakeholders across the urology device ecosystem

In conclusion, the urology devices landscape is defined by converging forces: clinical demand for less invasive and more effective therapies, technological advances that enable precision care and data integration, and commercial pressures driven by supply chain dynamics and evolving reimbursement models. These dynamics create both challenges and opportunities. Organizations that invest in clinically meaningful innovation, resilient supply chains, and evidence-based commercialization will differentiate themselves in an increasingly value-focused environment.

Attention to segmentation-across product types, technology formats, clinical applications, and end-user settings-enables more precise allocation of R&D and go-to-market resources. Regional strategies must be tailored to local regulatory expectations, procurement behaviors, and healthcare infrastructure to ensure successful entry and sustained adoption. Ultimately, the organizations that combine operational discipline, clinical partnership, and strategic agility will be best positioned to convert innovation into improved patient outcomes and durable commercial success.

Stakeholders should view the current period as an opportunity to refine pipelines, fortify supply resilience, and deepen clinical engagement, so that the promise of next-generation urology devices is realized in everyday care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urology Devices Market, by Product Type

  • 8.1. Continence Management
    • 8.1.1. Interventional Devices
    • 8.1.2. Noninterventional Devices
    • 8.1.3. Penile Prosthesis
  • 8.2. Endoscopy Devices
    • 8.2.1. Cystoscopes
    • 8.2.2. Nephroscopes
    • 8.2.3. Ureteroscopes
  • 8.3. Stone Management Devices
    • 8.3.1. Laser Systems
    • 8.3.2. Lithotripsy Devices
    • 8.3.3. Stone Removal Tools
  • 8.4. Ureteral Stents
    • 8.4.1. Drug Eluting Stents
    • 8.4.2. Metal Stents
    • 8.4.3. Polymer Stents
  • 8.5. Urinary Catheters
    • 8.5.1. External Catheters
    • 8.5.2. Foley Catheters
    • 8.5.3. Intermittent Catheters
  • 8.6. Urodynamic Devices
    • 8.6.1. EMG Systems
    • 8.6.2. Pressure Flow Analyzers

9. Urology Devices Market, by Technology

  • 9.1. Disposable
  • 9.2. Reusable

10. Urology Devices Market, by Application

  • 10.1. Benign Prostatic Hyperplasia
  • 10.2. Bladder Cancer
  • 10.3. Kidney Stones
  • 10.4. Urinary Incontinence
  • 10.5. Urinary Tract Infection

11. Urology Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Urology Clinics

12. Urology Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Urology Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Urology Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Urology Devices Market

16. China Urology Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Boston Scientific Corporation
  • 17.6. Coloplast A/S
  • 17.7. Cook Medical LLC
  • 17.8. Intuitive Surgical, Inc.
  • 17.9. Johnson & Johnson
  • 17.10. KARL STORZ SE & Co. KG
  • 17.11. Medtronic plc
  • 17.12. Olympus Corporation
  • 17.13. Richard Wolf GmbH
  • 17.14. Stryker Corporation
  • 17.15. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL UROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL UROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL UROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL UROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GCC UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 215. GCC UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. GCC UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 217. GCC UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 218. GCC UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. GCC UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. GCC UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. GCC UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. G7 UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 248. G7 UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. G7 UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 250. G7 UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 251. G7 UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 252. G7 UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 253. G7 UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. G7 UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. G7 UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 259. NATO UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 260. NATO UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 261. NATO UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 262. NATO UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 264. NATO UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 265. NATO UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. NATO UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)